Huaxia Eye Hospital Stock Beta
301267 Stock | 20.44 0.26 1.29% |
Huaxia Eye Hospital fundamentals help investors to digest information that contributes to Huaxia Eye's financial success or failures. It also enables traders to predict the movement of Huaxia Stock. The fundamental analysis module provides a way to measure Huaxia Eye's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Huaxia Eye stock.
Huaxia |
Huaxia Eye Hospital Company Beta Analysis
Huaxia Eye's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Huaxia Eye Beta | 0.67 |
Most of Huaxia Eye's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Huaxia Eye Hospital is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Competition |
In accordance with the recently published financial statements, Huaxia Eye Hospital has a Beta of 0.666. This is 22.56% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The beta for all China stocks is notably lower than that of the firm.
Huaxia Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Huaxia Eye's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Huaxia Eye could also be used in its relative valuation, which is a method of valuing Huaxia Eye by comparing valuation metrics of similar companies.Huaxia Eye is currently under evaluation in beta category among its peers.
As returns on the market increase, Huaxia Eye's returns are expected to increase less than the market. However, during the bear market, the loss of holding Huaxia Eye is expected to be smaller as well.
Huaxia Fundamentals
Return On Equity | 0.0946 | ||||
Return On Asset | 0.0562 | ||||
Profit Margin | 0.13 % | ||||
Operating Margin | 0.18 % | ||||
Current Valuation | 14.14 B | ||||
Shares Outstanding | 840 M | ||||
Shares Owned By Insiders | 84.28 % | ||||
Shares Owned By Institutions | 5.19 % | ||||
Price To Book | 2.92 X | ||||
Price To Sales | 4.20 X | ||||
Revenue | 4.09 B | ||||
Gross Profit | 1.55 B | ||||
EBITDA | 820.9 M | ||||
Book Value Per Share | 6.96 X | ||||
Earnings Per Share | 0.63 X | ||||
Target Price | 39.75 | ||||
Number Of Employees | 7.61 K | ||||
Beta | 0.67 | ||||
Market Capitalization | 19.98 B | ||||
Annual Yield | 0 % | ||||
Last Dividend Paid | 0.11 |
About Huaxia Eye Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Huaxia Eye Hospital's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Huaxia Eye using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Huaxia Eye Hospital based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Huaxia Stock
Huaxia Eye financial ratios help investors to determine whether Huaxia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Huaxia with respect to the benefits of owning Huaxia Eye security.